Dopaminergic Pathway Genes Influence Adverse Events Related to Dopaminergic Treatment in Parkinson's Disease

Dopaminergic pathway is the most disrupted pathway in the pathogenesis of Parkinson's disease. Several studies reported associations of dopaminergic genes with the occurrence of adverse events of dopaminergic treatment. However, none of these studies adopted a pathway based approach. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Redenšek, Sara, Flisar, Dušan, Kojović, Maja, Gregorič Kramberger, Milica, Georgiev, Dejan, Pirtošek, Zvezdan, Trošt, Maja, Dolžan, Vita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360186/
https://www.ncbi.nlm.nih.gov/pubmed/30745869
http://dx.doi.org/10.3389/fphar.2019.00008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360186/
https://www.ncbi.nlm.nih.gov/pubmed/30745869
http://dx.doi.org/10.3389/fphar.2019.00008

Ejemplares similares